They bought 5 million shares. Just…bought them. As if that solves anything. The paperwork was filed, the money exchanged hands. It’s all terribly efficient. And meaningless, when you think about it. Which, of course, we must do. Or not. It doesn’t much matter, in the long run.
NextEra recently published its earnings. The numbers were… adequate. A growth rate of 8.2% in earnings per share. They project something similar for the next few years. A predictable trajectory. They also speak of dividends, increasing at a respectable clip. It’s all very… orderly. One almost forgets the inherent precariousness of it all. The relentless demand for power, the aging infrastructure, the faint scent of desperation beneath the glossy reports.
Why, you ask? Well, it’s all thanks to those delightful macro fundamentals, or as I like to call them, the “random cosmic forces that make absolutely no sense.” Chief among these is the Trump tariffs, which have introduced more uncertainty into the market than a Babel fish at a multi-species diplomatic summit. Apparently, tariffs are now the new black hole for crypto prices.
They’re talking profits, too. Growing, they say. As if that ever changed. The real story, the one nobody wanted to shout from the rooftops, was buried in the earnings call. Memory chips. Suddenly, the little guys holding up the whole operation. A shortage, of course. What else would you expect? Demand for this AI nonsense is through the roof, and somebody has to make the bits that make it tick.
Apparently, this merger – with Synovus, another bank, naturally – diluted something called “tangible book value.” Tangible book value! What does that even mean? It sounds made up. And then there were “execution risks.” Risks! As if running a bank isn’t risky enough already. It’s like they’re actively looking for problems. The whole thing feels…unsettled. And now I’m unsettled.
The filings, those pale ghosts of transactions past, reveal a growing embrace. The fourth quarter saw this inward tide swell, bringing the fund’s holdings to 1,338,377 shares, valued at $86.93 million. A net increase of $18.90 million—a sum that doesn’t simply appear on a balance sheet, but represents a belief, a quiet confidence in the path forward. It is as if the bank, surveying the landscape, found its own soil most fertile.
Amongst these resurrected companies, one name surfaced with a particularly stubborn tenacity: Altria (MO +3.40%), the foremost purveyor of tobacco in this, our American domain. Over the past two years, its stock has rallied with a vigor that would shame a Cossack, exceeding a fifty percent ascent while the broader S&P 500 managed a mere forty. One is compelled to ask: what dark alchemy fuels this improbable resurgence? And, more importantly, can it endure? Let us, then, examine this curious case, and consider whether a modest ten thousand dollars—or perhaps a sum more substantial—might find a temporary haven within its smoldering embrace.
And right in the thick of it, leading the charge, is Nvidia. Now, Nvidia originally made its name building graphics cards for gamers – the sort of thing that lets you make explosions look convincingly, well, explosive. But they’ve cleverly pivoted, and now their GPUs – Graphics Processing Units – are the brains behind much of the AI boom. They currently command around 90% of the market, which, frankly, feels a bit like one company owning all the oxygen. They’ve also built a rather clever software platform called CUDA, and a strong networking business, which, as it turns out, is rather important when you’re trying to move vast quantities of data around. It’s a bit like building a superhighway for information, and Nvidia seems to have secured most of the toll booths.
For years, AbbVie has drawn sustenance from the fertile ground of immunology, most notably through Humira. Though the rains of exclusivity have ceased for that particular crop, the company has adapted, cultivating new strains like Skyrizi and Rinvoq. These are strong plants, already bearing considerable fruit – Skyrizi, a fifth-best seller globally, and Rinvoq following close behind. A man could build a comfortable life on such a harvest.
XRP had a run last year. A quick burst, like a cheap firework. Climbed seventy-one percent, then coughed up ten. The story? A legal tangle with the SEC. A squabble over whether a token was a security, or just…air. They dropped the appeal, and the optimists started building castles on quicksand. Stablecoins, ETFs… the usual song and dance.